Pillstats
Rx only · Ointment · Topical

Mupirocin

Mupirocin

21 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US30 NDCs
21 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)42372
US makers21 labelers
Packages39
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.057$0.113$0.170$0.227Dec 2025Apr 2026Jul 2026
$0.197
Latest avg · Jul 22, 2026
+4%
Since Dec 17, 2025
21
Active US suppliers
18%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

484K969K1.5M1.9M2025 Q12025 Q22025 Q32025 Q42026 Q1
1.3M
Rx · 2026 Q1
29.5M
Units dispensed
-2%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it21 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown4SUPPLYING
Sportpharm LLCunknown3SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown3SUPPLYING
NuCare Pharmaceuticals, Inc.unknown3SUPPLYING
Encube Ethicals, Inc.unknown3SUPPLYING
Bryant Ranch Prepackrepackager3SUPPLYING
Lohxaunknown2SUPPLYING
ADVANCED RX PHARMACY OF TENNESSEE, LLCunknown2SUPPLYING
PAI Holdings, LLC dba PAI Pharmaunknown2SUPPLYING
Padagis Israel Pharmaceuticals Ltdunknown2SUPPLYING
Preferred Pharmaceuticals Inc.unknown2SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
AvPAKunknown1SUPPLYING
St. Mary's Medical Park Pharmacyunknown1SUPPLYING

+ 6 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 30, 2024
    RECALLRecall (Class II): Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513…

    Subpotent Drug — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Product was distributed nationwide within the United States.

  • Apr 13, 2022
    RECALLRecall (Class II): Mupirocin Ointment, USP 2%, 22 grams tube, Rx only, MFG: Teva Pharma USA, NDC 0093-1010-42, MFG: Teva Pharma USA

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.